Naloxone Workgroup
|
Research Initiative
|
CDC, FDA, SAMHSA
|
NIDA
|
2012
|
|
Nanotechnology Characterization Laboratory
|
Research Initiative
|
FDA
|
NCI, NIEHS
|
2004
|
|
National Asthma Control Initiative/National Asthma Education and Prevention Program
|
Advisory Group
|
CDC, FDA
|
NHLBI, NIAID, NIEHS
|
2008
|
|
National Asthma Education and Prevention Program Federal Liaison Group on Asthma (FLGA)
|
Advisory Group
|
AHRQ, ATSDR, CDC, CMS, FDA, HRSA, OS
|
NHLBI, NIA, NIAID, NICHD, NIEHS, NIMHD, NINR
|
1998
|
|
National Blood Disorders Program
|
Advisory Group
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
NHLBI, NIMHD
|
2011
|
|
National Food and Nutrient Analysis Program (NFNAP)
|
Research Initiative
|
CDC, FDA, IHS
|
NCI, NEI, NHLBI, NIA, NICHD, NIDCR, NIDDK, OD/ DPCPSI/ ODP, OD/ DPCPSI/ ORWH
|
1997
|
|
National Health and Nutrition Examination Survey (NHANES)
|
Health Survey
|
CDC, FDA, OS
|
NCI, NHLBI, NIA, NIDDK, OD/ DPCPSI, OD/ DPCPSI/ ODP
|
1999
|
|
National Interagency Confederation for Biological Research
|
Other
|
CDC, FDA
|
NCI, NIAID
|
2002
|
|
National Kidney Disease Education Program
|
Public Education Campaign
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
NHLBI, NIDDK
|
1998
|
|
National Prevention Strategy
|
Advisory Group
|
ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NCI, NHLBI, NIDDK, OD/ DPCPSI
|
2010
|
|
National Program to Reduce Cardiovascular Risk (NPRCR) Coordinating Committee
|
Advisory Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NHLBI
|
2011
|
|
National Program to Reduce Cardiovascular Risk (NPRCR) Federal Subcommittee
|
Advisory Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NCI, NHLBI, NIDDK, NIMHD, NINDS, OD/ DPCPSI/ ODP
|
2012
|
|
National Robotics Initiative
|
Research Initiative
|
FDA
|
NCATS, NIA, NIBIB, NICHD, NINDS, NINR
|
2009
|
|
National Science Advisory Board for Biosecurity (NSABB)
|
Advisory Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2004
|
|
NCI / FDA- Federal Investigator Registry of Biomedical Information Research Data (FIREBIRD)
|
Resource Development
|
FDA
|
NCI
|
2004
|
|
NCI/FDA Memorandum of Understanding for Proteomics
|
Research Initiative
|
FDA
|
NCI
|
2006
|
|
Neural Interfaces Conference
|
Meeting/ Workshop
|
FDA
|
CSR, NEI, NIA, NIBIB, NICHD, NIDCD, NINDS
|
2006
|
|
Newborn Drug Development Planning committee
|
Other
|
FDA
|
NHLBI, NICHD, NLM
|
2011
|
|
Next-Generation DNA Sequencing as a Tool for Clinical Decision-Making in Cancer Patient Management
|
Meeting/ Workshop
|
FDA
|
NCI
|
2012
|
|
NIAID International Tuberculosis (TB) Working Group
|
Other
|
AHRQ, CDC, FDA, IHS, OS
|
FIC, NHLBI, NIAID, NICHD, NIDA
|
2003
|
|
NIH and US Food and Drug Administration On-line Courses: The Science of Sex and Gender in Human Health
|
Training Initiative
|
FDA
|
NCI, NIDA, NINR, OD/ DPCPSI/ ORWH
|
2011
|
|
NIH Guide for Grants and Contracts
|
Resource Development
|
AHRQ, CDC, FDA
|
CIT, CSR, OD/ OER
|
2007
|
|
NIH Recombinant DNA Advisory Committee
|
Advisory Group
|
CDC, FDA, OS
|
NCI, NHGRI, NIAID, NINDS, OD/ OSP
|
1974
|
|
NIH Translational Research Interest Group
|
Other
|
FDA
|
CC, CIT, CSR, NCATS, NCCAM, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ OER, OD/ OIR, OD/ OSP
|
2008
|
|
NIH-FDA Interagency Clinical Outcome Assessments Working Group
|
Advisory Group
|
FDA
|
CC, NCCAM, NCI, NHLBI, NIA, NIAMS, NICHD, NIDA, NIDDK, NIMH, NINDS, OD/ DPCPSI
|
2010
|
|
|